Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 13.03.2025
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
HealthCare Royalty and Heidelberg Pharma amend royalty financing agreement to provide for USD 20 million payment
Heidelberg Pharma extends cash runway into 2027
Ladenburg, Germany, 13 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company [ … ]
Thu, 13.03.2025
grenke AG
grenke generates a EUR 70.2 million profit in 2024 and maintains growth trajectory
Group earnings 2024 reach EUR 70.2 million (2023: EUR 86.7 million)
Proposed dividend of EUR 0.40 per share (2023: EUR 0.47)
Guidance for 2025: Leasing new business between EUR 3.2 and EUR 3.4 billion and Group earnings in the range of EUR 71 to 81 million
Bade [ … ]
Thu, 13.03.2025
INFICON Holding AG
Corporate ContactMatthias TröndleChief Financial Officer+423 388 3510 matthias.troendle@inficon.com'Ad hoc announcement pursuant to Art. 53 LR'
Announcement of INFICON Holding AGBad Ragaz/Switzerland, March 13, 2025
Fourth Quarter 2024: Record sales USD 177.5 million, plus 1.7% over prior year and 3.1% over Q3 2024; Operating profit USD 36.1 mi [ … ]
Thu, 13.03.2025
Swiss Re Ltd
Ad hoc announcement pursuant to Article 53 LR
Swiss Re maintains a strong capital position; Group Swiss Solvency Test (SST) ratio of 257% as of 1 January 2025[1]
Swiss Re proposes to elect Morten Hübbe and George Quinn as new members of the Board of Directors; Philip Ryan and Sir Paul Tucker will not stand for re-election
Swiss Re publishes Annu [ … ]
Thu, 13.03.2025
HELLA GmbH & Co. KGaA
LIPPSTADT (GERMANY)
13 March 2025
Fiscal Year 2024: FORVIA HELLA achieves solid financial results in a challenging industry environment
Currency-adjusted sales improve by 1.3 percent to €8.1 billion; reported sales of €8.0 billion remains at the previous year's level
Operating income falls to €446 million, among others due to underutiliza [ … ]
Thu, 13.03.2025
Nyxoah SA.
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results
FDA PMA Application Review Nearing Conclusion
Positioned for U.S. Commercial Launch in the First Quarter 2025
Mont-Saint-Guibert, Belgium – March 13, 2025, 7:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that dev [ … ]
Thu, 13.03.2025
AT&S Austria Technologie & Systemtechnik AG
AT&S and IFC sign sustainability-linked loan agreement to finance integrated circuit substrate plant in Malaysia
The International Finance Corporation— a member of the World Bank Group —confirmed a 250 million US-dollar loan for AT&S to further develop the AT&S plant in Kulim, Malaysia.
Leoben, March 13, 2025 – Yesterday evening, t [ … ]
Thu, 13.03.2025
DocMorris AG
Frauenfeld, 13 March 2025
These written materials or the information contained therein is not being issued and may not be distributed in the United States of America, Canada, Australia or Japan or any other jurisdiction in which the distribution or release would be unlawful or require registration or any other measure and does not constitute an of [ … ]
Thu, 13.03.2025
Romande Energie SA
Release of an ad hoc announcement pursuant to Art. 53 LR
Dear Sir or Madam
Please find attached copy of our press release:
Release of an ad hoc announcement (PDF)
Contact for media representatives
Contact for Investor Relations (IR)
Michèle Cassani
René Lauckner
Spokesperson
Head of Group Treasury
Phone: [ … ]
Thu, 13.03.2025
Rieter AG
Attached please find our latest media release.
The Annual Report 2024 as well as media and investor presentation can be found at: media kit
Kind regards,
Relindis Wieser
Head Group Marketing & Communication
Rieter AG . Klosterstrasse 20 . P.O. Box . CH-8406 Winterthur
T +41 52 208 70 45 relindis.wieser@rieter.com . www.rieter.com
End of [ … ]